Purchases and Sales Made in Q4 2022 in Adc Therapeutics Sa (ADCT)
This table provides information about the institutional ownership of Adc Therapeutics Sa (ADCT) during Q4 2022. The information is specifically focused on institutions that hold shares of ADC Therapeutics SA.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-412K- 12.06% |
$1.18M - $2.16M
|
3M
$4.81M
|
|
Feb 13, 2023
Q4 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-426K- 32.91% |
$1.22M - $2.23M
|
869K
$1.39M
|
|
Feb 16, 2023
Q4 2022
|
Moneta Group Investment Advisors LLC
St Louis, MO |
SELL
|
- |
-21.9M- 99.9% |
$62.9M - $115M
|
21.9K
$35.1K
|